Search alternatives:
increase decrease » increased release (Expand Search), increased crash (Expand Search)
slight decrease » slight increase (Expand Search)
high decrease » high degree (Expand Search), high disease (Expand Search), weight decreased (Expand Search)
increase decrease » increased release (Expand Search), increased crash (Expand Search)
slight decrease » slight increase (Expand Search)
high decrease » high degree (Expand Search), high disease (Expand Search), weight decreased (Expand Search)
-
701
-
702
Obese <i>mMgat2</i> and <i>HuMgat2</i> mice have elevated Krebs cycle intermediate levels.
Published 2025Subjects: -
703
-
704
-
705
Under steatotic conditions, primary <i>mMgat2</i> and <i>HuMgat2</i> hepatocytes induce apoptosis.
Published 2025Subjects: -
706
-
707
Obese <i>mMgat2</i> and <i>HuMgat2</i> mice show defects in solute transporter protein levels.
Published 2025Subjects: -
708
-
709
Obese <i>mMgat2</i> and <i>HuMgat2</i> mice develop MASLD and fibrosis on an HFD.
Published 2025Subjects: -
710
-
711
-
712
AZ10606120 treatment significantly increased cytotoxicity and reduced cell number in a dose-dependent manner.
Published 2025“…Cell numbers were significantly decreased in cells after treatment with AZ10606120 (50µM) compared to both temozolomide (TMZ; 50µM) treatment and untreated controls. …”
-
713
-
714
-
715
-
716
-
717
-
718
-
719
-
720